This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ruiz, S. Articles by Paramio, J. M. Search for Related Content PubMed PubMed Citation Articles by Ruiz, S. Articles by Paramio, J. M.

Unexpected Roles for pRb in Mouse Skin Carcinogenesis

¹ Program on Cell and Molecular Biology, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas and ² Department of Pathology, Hospital "12 de Octubre," Madrid, Spain

Requests for reprints: Jesús M. Paramio, Program on Cell and Molecular Biology, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas, Ave. Complutense 22, E28040 Madrid, Spain. Phone: 34-91-346-6051; Fax: 34-91-346-6484; E-mail: jesusm.paramio{at}ciemat.es.

The mouse skin carcinogenesis represents one of the best models for the understanding of malignant transformation, including the multistage nature of tumor development. The retinoblastoma gene product (pRb) plays a critical role in cell cycle regulation, differentiation, and inhibition of oncogenic transformation. In epidermis, Rb^–/– deletion leads to proliferation and differentiation defects. Numerous evidences showed the involvement of the retinoblastoma pathway in this model. However, the actual role of pRb is still unknown. To study the possible involvement of pRb in keratinocyte malignant transformation, we have carried out two-stage chemical skin carcinogenesis on Rb^F19/F19 (thereafter Rb^+/+) and Rb^F19/F19;K14Cre (thereafter Rb^–/–) animals. Unexpectedly, we found that Rb^–/– mice developed fewer and smaller papillomas than the Rb^+/+ counterparts. Moreover, the small size of the pRb-deficient tumors is associated with an increase in the apoptotic index. Despite this, pRb-deficient tumors display an increased conversion rate to squamous cell carcinomas. Biochemical analyses revealed that these characteristics correlate with the differential expression and activity of different pathways, including E2F/p19^arf/p53, PTEN/Akt, c-jun NH₂-terminal kinase/p38, and nuclear factor-B. Collectively, our findings show unexpected and hitherto nondescribed roles of pRb during the process of epidermal carcinogenesis.

This article has been cited by other articles:

				L. Tonnetti, S. Netzel-Arnett, G. A. Darnell, T. Hayes, M. S. Buzza, I. E. Anglin, A. Suhrbier, and T. M. Antalis SerpinB2 Protection of Retinoblastoma Protein from Calpain Enhances Tumor Cell Survival Cancer Res., July 15, 2008; 68(14): 5648 - 5657. [Abstract] [Full Text] [PDF]

				A. B. Martinez-Cruz, M. Santos, M. F. Lara, C. Segrelles, S. Ruiz, M. Moral, C. Lorz, R. Garcia-Escudero, and J. M. Paramio Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors Cancer Res., February 1, 2008; 68(3): 683 - 692. [Abstract] [Full Text] [PDF]

				E. S. Knudsen and K. E. Knudsen Retinoblastoma tumor suppressor: where cancer meets the cell cycle. Experimental Biology and Medicine, July 1, 2006; 231(7): 1271 - 1281. [Abstract] [Full Text] [PDF]

				J. DeGregori Surprising Dependency for Retinoblastoma Protein in Ras-Mediated Tumorigenesis Mol. Cell. Biol., February 15, 2006; 26(4): 1165 - 1169. [Full Text] [PDF]

				J. P. Williams, T. Stewart, B. Li, R. Mulloy, D. Dimova, and M. Classon The Retinoblastoma Protein Is Required for Ras-Induced Oncogenic Transformation Mol. Cell. Biol., February 15, 2006; 26(4): 1170 - 1182. [Abstract] [Full Text] [PDF]